The tumorigenic activities of PN are activated by binding to ITG and activating AKT/PKB‐mediated or FAK‐mediated signalling pathways leading to the increased cell survival, angiogenesis, invasion, metastasis and EMT of cancer cells.11 This evidence concerns the gene PTK2 and cancer.